Company Search:
Advanced Search
Sponsored Links
BB Biotech AG Company Snapshot
BB Biotech AG operates in the Investors sector. In addition to historical fundamental analyses, the complete report available to purchase compares BB Biotech AG with three other financial institutions in Europe: Blue Cap AG of GERMANY (2019 sales of 232.55 million Euros [US$272.62 million] of which 31% was Plastics Technology), Aforti Holding SA of POLAND (1.04 billion Polish New Zlotys [US$267.14 million] ), and Luxempart which is based in LUXEMBOURG (218.92 million Euros [US$256.65 million] ).

Sales Analysis. BB Biotech AG reported sales of 240.87 million Swiss Francs (US$263.25 million) for the year ending December of 2019. This represents an increase of 59.5% versus 2018, when the company's sales were 150.99 million Swiss Francs. Despite this increase, sales are still below the level achieved in 2017, when BB Biotech AG reported sales of 270.33 million Swiss Francs. The sales level in 2019 was fairly close to the level five years ago: in 2014, BB Biotech AG had sales of 222.15 million Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BB Biotech AG
  Stock Performance Chart for BB Biotech AG
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 65.65
(Figures in Swiss Francs)
1 Week 0.1%   13 Weeks -4.8%  
4 Weeks -7.2%   52 Weeks 8.8%  
BB Biotech AG Key Data:
  Ticker: BION Country: Switzerland
  Exchanges: OTH ZHR Major Industry: Diversified Financials
    Sub Industry: Investors
  2019 Sales 240,870,000
(Year Ending Jan 2020).
Employees: N/A
  Currency: Swiss Francs Market Cap: 3,637,010,000
  Fiscal Yr Ends: December Shares Outstanding: 55,400,000
  Share Type: Inhaberaktie Closely Held Shares: 1,575,215
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.